This study is in progress, not accepting new patients
A Study to Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS).
- at UCSF
- study startedestimated completion
- in progress, not accepting new patients
- Start Date
- Completion Date
- Mirum Pharmaceuticals, Inc.
- Genetics Home Reference - PFIC Mirum Pharmaceuticals homepage Genetics Home Reference - ALGS
- Phase 2 research study
- Study Type
- Expecting 12 study participants
- Last Updated